Related Experiment Video
Updated: Mar 11, 2026

11:30
Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins
Published on: August 31, 2019
25.4K
Selecting optimum protein nano-carriers for natural polyphenols using chemoinformatics tools
AbdelKader A Metwally1, Sherweit H El-Ahmady2, Rania M Hathout3
1Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
Summary
Computational tools can virtually select optimal protein carriers for natural compounds like resveratrol and curcumin. This approach enhances formulation development for potential cancer therapies, improving drug delivery and efficacy.
Area of Science:
- Pharmaceutical Sciences
- Computational Chemistry
- Nanotechnology
Background:
- Conventional drug formulation relies on experience and trial-and-error, often failing to achieve optimal results for therapeutic natural products.
- Selecting suitable carriers for natural compounds like resveratrol and curcumin is crucial for their medicinal application.
- Existing methods lack efficiency in identifying ideal drug-carrier pairings.
Purpose of the Study:
- To explore the virtual selection of optimal protein carriers for resveratrol and curcumin using chemoinformatics.
- To develop and evaluate a novel curcumin-gelatin nanoparticle formulation for breast cancer treatment.
- To demonstrate the utility of computational tools in optimizing drug formulation.
Main Methods:
- Utilized chemoinformatics tools, including molecular dynamics and molecular docking, to assess protein-nanoparticle interactions.
- Compared albumin and gelatin nanoparticles as carriers for resveratrol and curcumin.
- Prepared and tested a new curcumin-gelatin nanoparticle formulation against MCF-7 breast cancer cells.
Main Results:
- The computational approach successfully identified optimal protein carriers for resveratrol and curcumin.
- A novel curcumin-gelatin nanoparticle formulation exhibited cytotoxicity against MCF-7 breast cancer cells with an IC50 of 64.8µg/ml.
- Molecular dynamics and docking simulations accurately predicted effective drug-carrier interactions.
Conclusions:
- Computational tools offer a superior alternative to traditional methods for selecting drug-carrier pairs.
- This study validates the use of in silico methods for designing effective drug formulations.
- The findings support the development of targeted nanomedicines for cancer therapy.

